MétaCan
Menu
Back to cohort

Adjuvant chemotherapy in the management of cholangiocarcinoma: A 10-year cohort analysis.

2013· article· en· W2590769060 on OpenAlexaff
Tahir Shaikh, Timothy R. Asmis, Derek J. Jonker

Bibliographic record

VenueJournal of Clinical Oncology · 2013
Typearticle
Languageen
FieldMedicine
TopicCholangiocarcinoma and Gallbladder Cancer Studies
Canadian institutionsOttawa HospitalUniversity of Ottawa
Fundersnot available
KeywordsMedicineChemotherapyStage (stratigraphy)Internal medicineCohortSurgeryRadiation therapyRetrospective cohort studyGastroenterologyIncidence (geometry)AdenocarcinomaCancer

Abstract

fetched live from OpenAlex

330 Background: The evidence regarding treatment outcomes from chemotherapy for cholangiocarcinomas (CCAs) is limited because of the high mortality rate and a low overall incidence. Most studies are small and include a heterogeneous group of tumors (biliary, pancreatic, hepatocellular, and ampullary cancers) that each have a unique natural history and response to chemotherapy. The aim of this study is to assess the effect of chemotherapy on survival of patients with surgically resected (R0-negative margins/R1-positive margins) and unresectable (R2-gross residual tumor/metastatic) CCAs. Methods: In a retrospective single-center study, data on all CCA patients (n=209) from 1998 to 2008 were evaluated. Survival time was assessed as a primary outcome measure. Patient demographics, pathological diagnosis, performance status, chemo-radiation therapy, surgical resection, relapse rates and laboratory outcomes were assessed. Results: 209 cases of CCA (female n=116, mean age 65, adenocarcinoma n=166 (79.4%), stage 0/1 n=17 (8.1%), stage 2/3 n=99 (47.3%), stage 4 n=93 (44.4 %)) were identified. 162 (77.5%) patients received treatment (surgical resection n=118 (R0 n=53, R1 n=21) chemotherapy n=85, radiation therapy n=33). Median overall survival (months) was 9.8 (no treatment =2.1, treatment =12.4 (R0 and R1 surgical resection =21.9 and 10.9 p<.001). Median survival (months) in patients with surgical resection with and without adjuvant chemotherapy was 22.2 vs 21.9 p=0.75 for R0 resection and 18.1 vs 10.9 p=0.10 for R1 resection. In patients with unresectable tumor, median survival with and without chemotherapy was 10.7 and 2.1 months (p<.05) respectively. Conclusions: CCAs are associated with poor survival if untreated. Complete surgical resection was associated with significantly improved survival outcomes. Adjuvant chemotherapy in the setting of R0 resection did not improve survival compared to surgical monotherapy. In the setting of unresectable or metastatic CCA, survival was significantly prolonged in patients who received palliative chemotherapy. Although not conclusive, these data suggests the use of adjuvant chemotherapy in the setting resection with positive margins (R1) may also prolong survival.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.076
GPT teacher head0.425
Teacher spread0.348 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicCholangiocarcinoma and Gallbladder Cancer StudiesFrench-language works237,207